CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.

 

Begin main content

Search

We found 7163 result(s)

budesonide/ glycopyrronium /formoterol fumarate (TBC)

Last Updated: February 23, 2021
Result type: Reports
Product Line: Reimbursement Review
Generic Name: budesonide/ glycopyrronium /formoterol fumarate
Indications: budesonide/ glycopyrronium /formoterol fumarate is a combination of an inhaled corticosteroid (ICS), long-acting muscarinic antagonist (LAMA), and a long-acting beta2-adrenergic agonist (LABA), indicated for the long-term maintenance treatment to reduce exacerbations of chronic obstructive pulmonary disease (COPD), and to relieve symptoms in patients with COPD, including chronic bronchitis and/or emphysema.

  • Brand Name: TBC
  • Manufacturer: AstraZeneca Canada Inc.
  • Project Number: SR0675-000
  • Project Status: Active
  • Submission Type: Initial

risperidone (Perseris )

Last Updated: February 23, 2021
Result type: Reports
Product Line: Reimbursement Review
Generic Name: risperidone
Indications: ​Treatment of schizophrenia in adults.

  • Brand Name: Perseris
  • Manufacturer: HLS Therapeutics Inc.
  • Project Number: SR0671-000
  • Project Status: Active
  • Submission Type: Initial

givosiran (Givlaari)

Last Updated: February 23, 2021
Result type: Reports
Product Line: Reimbursement Review
Generic Name: givosiran
Indications: ​Treatment of acute hepatic porphyria (AHP) in adults

  • Brand Name: Givlaari
  • Manufacturer: Alnylam Netherlands B.V.
  • Project Number: SR0679-000
  • Project Status: Received
  • Submission Type: Initial

daunorubicin and cytarabine (Vyxeos)

Last Updated: February 23, 2021
Result type: Reports
Product Line: Reimbursement Review
Generic Name: daunorubicin and cytarabine
Indications: For the treatment of adults with newly diagnosed therapy-related acute myeloid leukaemia (t-AML) or AML with myelodysplasia-related changes (AML-MRC).

  • Brand Name: Vyxeos
  • Manufacturer: Jazz Pharmaceuticals Canada Inc.
  • Project Number: PC0237-000
  • Project Status: Active
  • Submission Type: Initial

Workshop - Survival Analysis and Decision Modelling in R

Event Date: February 24, 2021
Result type: Events

Audience: Of interest to HTA producers. Level: Intermediate. What you’ll learn: This is an introduction to survival analysis methods for model-based economic evaluations through practical examples in R. The advantages and disadvantages of each method will be discussed. Dr. Petros Pechlivanoglou, The Hospital for Sick Children (SickKids) N...

Levetiracetam (pdp-levETIRAcetam)

Last Updated: February 9, 2021
Result type: Reports
Product Line: Reimbursement Review
Generic Name: Levetiracetam
Indications: Adjunctive therapy for: Adults management of patients with epilepsy who are not satisfactorily controlled by conventional therapyPediatrics partial onset seizures with or without secondary generalization in adolescents, children and infants from 1 month of age with epilepsy. myoclonic seizures in adolescents from 12 years of age with Juvenile Myoclonic Epilepsy. primary generalized tonic-clonic seizures in adolescents from 12 years of age with Idiopathic Generalized Epilepsy.

  • Brand Name: pdp-levETIRAcetam
  • Manufacturer: Pendopharm, a division of Pharmascience Inc.
  • Project Number: SR0653-000
  • Project Status: Active
  • Submission Type: Initial